furafylline

cytochrome P450 family 1 subfamily A member 2 ; Homo sapiens







64 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35246464 Estimation of Fraction Metabolized by Cytochrome P450 Enzymes Using Long-Term Cocultured Human Hepatocytes. 2022 May 1
2 35599345 In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions. 2022 Jun 1
3 30390556 Study on the inhibitory effect of furafylline and troleandomycin in the 7-methoxyresorufin-O-demethylase and nifedipine oxidase activities in hepatic microsomes from four poultry species using high-performance liquid chromatography coupled with fluorescence and ultraviolet detection. 2019 Feb 5 2
4 29785610 Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes. 2018 Dec 1
5 26856397 Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3. 2016 Mar 1
6 23898916 DNA adducts of the tobacco carcinogens 2-amino-9H-pyrido[2,3-b]indole and 4-aminobiphenyl are formed at environmental exposure levels and persist in human hepatocytes. 2013 Sep 16 1
7 22266842 Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist. 2012 Apr 1
8 23106957 In vitro characterization of the oxidation of a pyridinium metabolite of haloperidol by human placenta: the effect of smoking. 2012 2
9 21336516 Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. 2011 Mar 1
10 21726170 In vitro metabolism of nobiletin, a polymethoxy-flavonoid, by human liver microsomes and cytochrome P450. 2011 Nov 1
11 21755496 Development of a whole-cell screening system for evaluation of the human CYP1A2-mediated metabolism. 2011 Dec 1
12 19204080 A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes. 2009 May 1
13 17823234 Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation? 2007 Dec 1
14 16771648 Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. 2006 May 1
15 16814747 Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity. 2006 Aug 28 1
16 15649641 Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes. 2005 Mar 1
17 15766918 Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2. 2005 Feb 28 4
18 15276085 Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. 2004 Aug 15 1
19 15279827 Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline. 2004 Aug 8 1
20 15537169 The in vitro metabolism of desglymidodrine, an active metabolite of prodrug midodrine by human liver microsomes. 2004 Jul-Sep 1
21 15696928 [Mechanism of mono-hydroxylation of daidzein in human liver microsomes]. 2004 Nov 2
22 12495659 The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line. 2003 Jan 1
23 12569440 Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate. 2003 1
24 12721102 Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. 2003 Apr 1
25 12867277 Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein. 2003 Aug 2
26 11744615 CYP1A-mediated metabolism of the Janus kinase-3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline: structural basis for inactivation by regioselective O-demethylation. 2002 Jan 1
27 12180536 The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. 2002 Jul 1
28 12523495 Perazine as a potent inhibitor of human CYP1A2 but not CYP3A4. 2002 Jul-Aug 1
29 15618695 Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. 2002 1
30 11231111 High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. V. Validation of a direct injection/on-line guard cartridge extraction--tandem mass spectrometry method for CYP1A2 inhibition assessment. 2001 Feb 1
31 10727902 Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons. 2000 Mar 23 1
32 10992045 A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition. 2000 Aug 1
33 11095582 Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid. 2000 Dec 2
34 11315102 Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1. 2000 Oct 1
35 11315104 Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms. 2000 Oct 1
36 11790342 Catalytic properties of CYP1A isoforms in the liver of an agnathan (Lampetra fluviatilis) and two species of teleost (Pleuronectes flesus, Anguilla anguilla). 2000 Feb 1
37 10078840 Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. 1999 Jan 1
38 10215755 Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. 1999 Mar 1
39 10359460 Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine. 1999 Apr 1 1
40 10418968 Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. 1999 Jun 1 1
41 10460803 Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. 1999 Sep 1
42 10553725 Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. 1999 Aug 1
43 9435160 Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. 1998 Jan 1
44 9491822 Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. 1998 Feb 1
45 9585555 Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. 1998 May 19 4
46 9825830 In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol. 1998 Oct 1
47 9884161 Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. 1998 Dec 1
48 9202738 Assessing human risk to heterocyclic amines. 1997 May 12 1
49 9351903 Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2. 1997 Nov 1
50 9394024 Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes. 1997 Dec 1